Baidu
map
ACS CHEM NEUROSCI 润色咨询

ACS Chemical Neuroscience

出版年份:2010 年文章数:345 投稿命中率: 开通期刊会员,数据随心看

出版周期:Biweekly 自引率:9.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2023-08-28 ms6000002054670522 来自山东省

    现在审稿要多久呀,快一个月了还是under review

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2022-02-09 ms5000001426662793

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:现在超慢,返修2次了

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2022-03-16 兵临城下house

    有人知道这个杂志外审后的拒稿率大概是多少吗?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2022-03-02 ms5000001426662793

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:药物化学
    经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2021-12-29 衣谷

    评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    回复评审的意见和期刊编辑的意见有什么不同?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2018-06-28 sumlower

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2020-04-03 lekai726

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2018-11-11 sumlower

    没有版面费瑞琼 2018-10-29 00:00:00 发表:
    恭喜!要交版面费吗?

    瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2154919, encodeId=c2ed21549196e, content=现在审稿要多久呀,快一个月了还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67108233485, createdName=ms6000002054670522, createdTime=Mon Aug 28 10:40:16 CST 2023, time=2023-08-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1191517, encodeId=7189119151e0a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:现在超慢,返修2次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Feb 09 20:42:04 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203120, encodeId=e1e31203120c2, content=有人知道这个杂志外审后的拒稿率大概是多少吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10a05503477, createdName=兵临城下house, createdTime=Wed Mar 16 15:38:42 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198584, encodeId=974911985844f, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:药物化学<br>经验分享:美国化学会的子刊!影响因子虽不高,但文章质量很不错,之前属于药物化学一区!普遍高于一般的药物化学杂志!大约与EJMC相当!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5a35553126, createdName=ms5000001426662793, createdTime=Wed Mar 02 08:32:04 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103530, encodeId=7af31103530a5, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103529, encodeId=64ae1103529d8, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558580, encodeId=3adc55858055, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Thu Jun 28 16:27:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588092, encodeId=f90d5880922d, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:ACS旗下好多高分杂志。这本杂志比较讲创新吧,药物化学,新药物的应用都可以投,如果是机制的研究做的全一些比较好。三个审稿人,每个人都提了不少意见,一条一条认真修改,编辑人还挺好的,但是比较严格,一审给我拒了,但给了我重投的机会,保持在四分上下,今年预计4.5分,按稿件量来看,大概四分之一到三分之一的接收率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b3652595, createdName=lekai726, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563084, encodeId=95ff563084b5, content=没有版面费<span class="quote">瑞琼 2018-10-29 00:00:00 发表:<br>恭喜!要交版面费吗?</span>, beContent=瑞琼 2018-10-29 00:00:00 发表: 恭喜!要交版面费吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06ef1724159, createdName=sumlower, createdTime=Sun Nov 11 00:00:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562501, encodeId=c630562501fc, content=恭喜!要交版面费吗?<span class="quote">sumlower 2018-06-28 16:27:00 发表:<br>很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力</span>, beContent=sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fe2070317, createdName=瑞琼, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=)]
    2018-10-29 瑞琼

    恭喜!要交版面费吗?sumlower 2018-06-28 16:27:00 发表:
    很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力

    sumlower 2018-06-28 16:27:00 发表: 很好的杂志,稿件处理速度很快,一审大概一月,给了小修,审稿人意见比较专业,但没有刁钻的问题,花了10天左右小修上传后一天就接收了,从投稿到接收差不多一个半月,非常给力

    0

共30条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map